725 related articles for article (PubMed ID: 34338718)
1. Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.
Klein P; Devinsky O; French J; Harden C; Krauss GL; McCarter R; Sperling MR
JAMA Neurol; 2021 Sep; 78(9):1118-1127. PubMed ID: 34338718
[TBL] [Abstract][Full Text] [Related]
2. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Leppien EE; Doughty BJ; Hurd KL; Strong KN; Piper BJ; McCall KL
Clin Drug Investig; 2023 Jun; 43(6):393-399. PubMed ID: 37184612
[TBL] [Abstract][Full Text] [Related]
3. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
[TBL] [Abstract][Full Text] [Related]
4. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
Privitera M; Richy FF; Schabert VF
Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
7. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database.
Porwal MH; Razzak AN; Kumar V; Obeidat AZ; Sharma U
Epilepsy Res; 2024 Jul; 203():107382. PubMed ID: 38761467
[TBL] [Abstract][Full Text] [Related]
8. Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.
Redden L; Pritchett Y; Robieson W; Kovacs X; Garofalo M; Tracy K; Saltarelli M
Ann Gen Psychiatry; 2011 Jan; 10(1):1. PubMed ID: 21244672
[TBL] [Abstract][Full Text] [Related]
9. Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
Stern S; Weingarten M; Mandapati S; Ferrari L; Wade CT
Epilepsy Res; 2023 Nov; 197():107207. PubMed ID: 37741165
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
[TBL] [Abstract][Full Text] [Related]
11. Suicidality in people taking antiepileptic drugs: What is the evidence?
Bell GS; Mula M; Sander JW
CNS Drugs; 2009; 23(4):281-92. PubMed ID: 19374458
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Andermann E; Biton V; Benbadis SR; Shneker B; Shah AK; Carreño M; Trinka E; Ben-Menachem E; Biraben A; Rocha F; Gama H; Cheng H; Blum D;
Epilepsy Behav; 2018 May; 82():119-127. PubMed ID: 29604484
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.
Yang Y; Shangguan Y; Wang X; Liu R; Shen Z; Tang M; Jiang G
Front Neurol; 2023; 14():1307296. PubMed ID: 38264091
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of add-on antiseizure medications for focal epilepsy: A network meta-analysis.
Zhang H; Ou Z; Zhang E; Liu W; Hao N; Chen Y; Liu Y; Ye H; Zhou D; Wu X
Epilepsia Open; 2024 Jun; ():. PubMed ID: 38888005
[TBL] [Abstract][Full Text] [Related]
15. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
[TBL] [Abstract][Full Text] [Related]
16. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
[TBL] [Abstract][Full Text] [Related]
17. Suicidality and antiepileptic drugs in people with epilepsy: an update.
Mula M
Expert Rev Neurother; 2022 May; 22(5):405-410. PubMed ID: 35394392
[TBL] [Abstract][Full Text] [Related]
18. Failure to use new breakthrough treatments for epilepsy.
Klein P; Krauss GL; Steinhoff BJ; Devinsky O; Sperling MR
Epilepsia; 2023 Jun; 64(6):1458-1465. PubMed ID: 36855241
[TBL] [Abstract][Full Text] [Related]
19. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis.
Sandhu JK; Wu KK; Bui TL; Armstrong AW
JAMA Dermatol; 2019 Feb; 155(2):178-187. PubMed ID: 30540348
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of cenobamate for focal seizures in people with drug-resistant epilepsy.
Laskier V; Agyei-Kyeremateng KK; Eddy AE; Patel D; Mulheron S; James S; Thomas RH; Sander JW
Epilepsia; 2023 Apr; 64(4):843-856. PubMed ID: 36625423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
